Five9 raises target price to $40 from $34
FIVN•Barclays raised its target price for Five9 to $40 from $34.
Related News
Game Your Game posts investor presentation on website
GYGY•
Horizon Space Acquisition I agrees to merge with ArcheNova Biotech in deal targeting Nasdaq listing
HSPO•
Tilray Medical wins INFARMED approval for in-house EU-GMP quality testing at Portugal facility
TLRY•
Agora CEO Zhao Bin reports $441,867 purchase of company shares
API•
Alkermes to present Phase 3 REVITALYZ trial results for LUMRYZ in idiopathic hypersomnia at Sleep Europe 2026
ALKS•